About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [424 citations: 101–200 of 423 articles]

Articles published in Chemotherapy Research and Practice have been cited 424 times. The following is a list of the 423 articles that have cited the articles published in Chemotherapy Research and Practice.

  • Koji Matsuo, Seiji Mabuchi, Mika Okazawa, Mahiru Kawano, Hiromasa Kuroda, Shoji Kamiura, and Tadashi Kimura, “Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors,” Journal Of Gynecologic Oncology, vol. 26, no. 1, pp. 3–11, 2015. View at Publisher · View at Google Scholar
  • Federica Maria Di Maggio, Luigi Minafra, Giusi Irma Forte, Francesco Paolo Cammarata, Domenico Lio, Cristina Messa, Maria Carla Gilardi, and Valentina Bravatà, “Portrait of inflammatory response to ionizing radiation treatment,” Journal of Inflammation, vol. 12, no. 1, 2015. View at Publisher · View at Google Scholar
  • Xu Liu, Alvin Kung, Brock Malinoski, G. K. Surya Prakash, and Chao Zhang, “Development of Alkyne-Containing Pyrazolopyrimidines To Overcome Drug Resistance of Bcr-Abl Kinase,” Journal of Medicinal Chemistry, 2015. View at Publisher · View at Google Scholar
  • Rajath Othayoth, Pardhasaradhi Mathi, Khaggeswar Bheemanapally, Lavanya Kakarla, and Mahendran Botlagunta, “Characterization of vitamin-cisplatin-loaded chitosan nano-particles for chemoprevention and cancer fatigue,” Journal Of Microencapsulation, vol. 32, no. 6, pp. 578–588, 2015. View at Publisher · View at Google Scholar
  • Laura Cosmai, Maurizio Gallieni, and Camillo Porta, “Renal toxicity of anticancer agents targeting HER2 and EGFR,” Journal Of Nephrology, vol. 28, no. 6, pp. 647–657, 2015. View at Publisher · View at Google Scholar
  • Roberta Salaroli, Alice Ronchi, Francesca Romana Buttarelli, Filippo Cortesi, Valeria Marchese, Elena Della Bella, Cristiano Renna, Caterina Baldi, Felice Giangaspero, and Giovanna Cenacchi, “Wnt activation affects proliferation, invasiveness and radiosensitivity in medulloblastoma,” Journal Of Neuro-Oncology, vol. 121, no. 1, pp. 119–127, 2015. View at Publisher · View at Google Scholar
  • Kevin A. Harvey, Zhidong Xu, M. Reza Saaddatzadeh, Haiyan Wang, Karen Pollok, Aaron A. Cohen-Gadol, and Rafat A. Siddiqui, “Enhanced anticancer properties of lomustine in conjunction with docosahexaenoic acid in glioblastoma cell lines,” Journal Of Neurosurgery, vol. 122, no. 3, pp. 547–556, 2015. View at Publisher · View at Google Scholar
  • Sudeshna Mukherjee, Sayan Ghosh, Dipesh Kr. Das, Priyanka Chakraborty, Sreetama Choudhury, Payal Gupta, Arghya Adhikary, Sanjit Dey, and Sreya Chattopadhyay, “Gold-conjugated green tea nanoparticles for enhanced anti-tumor activities and hepatoprotection - synthesis, characterization and in vitro evaluation,” Journal Of Nutritional Biochemistry, vol. 26, no. 11, pp. 1283–1297, 2015. View at Publisher · View at Google Scholar
  • Joshua Seth Eaton, Paul E. Miller, Mark J. Mannis, and Christopher J. Murphy, “Ocular Adverse Events Associated with Antibody-Drug Conjugates in Human Clinical Trials,” Journal Of Ocular Pharmacology And Therapeutics, vol. 31, no. 10, pp. 589–604, 2015. View at Publisher · View at Google Scholar
  • Sunil S. Adav, Ho Hee Hwa, Dominique de Kleijn, and Siu Kwan Sze, “Improving Blood Plasma Glycoproteome Coverage by Coupling Ultracentrifugation Fractionation to Electrostatic Repulsion-Hydrophilic Interaction Chromat,” Journal Of Proteome Research, vol. 14, no. 7, pp. 2828–2838, 2015. View at Publisher · View at Google Scholar
  • Marta Simo, James C. Root, Lucia Vaquero, Pablo Ripolles, Josep Jove, Tim Ahles, Arturo Navarro, Felipe Cardenal, Jordi Bruna, and Antoni Rodriguez-Fornells, “Cognitive and Brain Structural Changes in a Lung Cancer Population,” Journal Of Thoracic Oncology, vol. 10, no. 1, pp. 38–45, 2015. View at Publisher · View at Google Scholar
  • Ee Xien Ng, Miles A. Miller, Tengyang Jing, Doug A. Lauffenburger, and Chia-Hung Chen, “Low-volume multiplexed proteolytic activity assay and inhibitor analysis through a pico-injector array,” Lab Chip, vol. 15, no. 4, pp. 1153–1159, 2015. View at Publisher · View at Google Scholar
  • John Hornberger, Fred R. Hirschc, Qianyi Li, and Ray D. Page, “Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: Extended analysis ,” Lung Cancer, vol. 88, no. 2, pp. 223–230, 2015. View at Publisher · View at Google Scholar
  • Denis Moro-Sibilot, Egbert Smit, Javier de Castro Carpeno, Krzysztof Lesniewski-Kmak, Joachim Aerts, Rosa Villatoro, Kees Kraaij, Karim Nacerddine, Yulia Dyachkova, Karen T. Smith, Kaisa Taipale, Allicia C. Girvan, Carla Visseren-Grul, and Philipp A. Schnabel, “Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME pros,” Lung Cancer, vol. 88, no. 2, pp. 215–222, 2015. View at Publisher · View at Google Scholar
  • Engy M. Aboelnaga, Mohamed A. Daoud, Entesar I. Eladl, and Amir M. Zaid, “Induction FOLFOX followed by preoperative hyperfractionated radiotherapy plus bolus 5-fluorouracil in locally advanced rectal carcinoma: single arm ph,” Medical Oncology, vol. 32, no. 4, 2015. View at Publisher · View at Google Scholar
  • Barbara Crone, Michael Aschner, Tanja Schwerdtle, Uwe Karst, and Julia Bornhorst, “Elemental bioimaging of Cisplatin in Caenorhabditis elegans by LA-ICP-MS,” Metallomics, vol. 7, no. 7, pp. 1189–1195, 2015. View at Publisher · View at Google Scholar
  • Sílvia Couto, José Luís Metello, Sandra Ramos, Pedro Ferreira, Raquel Ilgenfritz, Pedro Sá e Melo, and Eman Elgindy, “Gestational trophoblastic neoplasia after in vitro fertilization and embryo-transfer,” Middle East Fertility Society Journal, 2015. View at Publisher · View at Google Scholar
  • Tomasz Jarzabek, Monika Rucinska, Wojciech Rogowski, Marzena Lewandowska, Jerzy Tujakowski, Maja Habib, Anna Kowalczyk, Agnieszka Byszek, Rafal Dziadziuszko, and Sergiusz Nawrocki, “CA-SSR1 Polymorphism in Intron 1 of the EGFR Gene in Patients with Malignant Tumors Who Develop Acneiform Rash Associated with the Use of Cetuximab,” Molecular Diagnosis & Therapy, vol. 19, no. 2, pp. 79–89, 2015. View at Publisher · View at Google Scholar
  • Zéna Wimana, G. Gebhart, T. Guiot, B. Vanderlinden, R. Morandini, G. Doumont, F. Sherer, G. Van Simaeys, S. Goldman, G. Ghanem, and P. Flamen, “Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [89Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model,” Molecular Imaging and Biology, 2015. View at Publisher · View at Google Scholar
  • Hao Wu, Qiang Liu, Tao Cai, Yu-Dan Chen, and Zhi-Fei Wang, “Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma,” Molecular Medicine Reports, vol. 12, no. 4, pp. 5461–5466, 2015. View at Publisher · View at Google Scholar
  • P. Anoosha, Liang-Tsung Huang, R.Sakthivel, D. Karunagaran, and M. Michael Gromiha, “Discrimination of Driver and Passenger Mutations in Epidermal Growth Factor Receptor in Cancer,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2015. View at Publisher · View at Google Scholar
  • Namrata Bora-Singhal, Deepak Perumal, Jonathan Nguyen, and Srikumar Chellappan, “Gli1-Mediated Regulation of Sox2 Facilitates Self-Renewal of Stem-Like Cells and Confers Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer,” Neoplasia, vol. 17, no. 7, pp. 538–551, 2015. View at Publisher · View at Google Scholar
  • James P. Caruso, Or Cohen-Inbar, Mark H. Bilsky, Peter C. Gerszten, and Jason P. Sheehan, “Stereotactic radiosurgery and immunotherapy for metastatic spinal melanoma,” Neurosurgical Focus, vol. 38, no. 3, pp. E6, 2015. View at Publisher · View at Google Scholar
  • Sivanantham Banudevi, Sethuraman Swaminathan, and Krishnan Uma Maheswari, “Pleiotropic Role of Dietary Phytochemicals in Cancer: Emerging Perspectives for Combinational Therapy,” Nutrition and Cancer, pp. 1–28, 2015. View at Publisher · View at Google Scholar
  • Angelika Kaczynska, Joanna Swierczynska, and Anna Herman-Antosiewicz, “Sensitization of HER2 Positive Breast Cancer Cells to Lapatinib Using Plants-Derived Isothiocyanates,” Nutrition And Cancer-An International Journal, vol. 67, no. 6, pp. 976–986, 2015. View at Publisher · View at Google Scholar
  • Analhuda Abdullah Tahir, Nur Fathiah Abdul Sani, Noor Azian Murad, Suzana Makpol, Wan Zurinah Wan Ngah, and Yasmin Anum Mohd Yusof, “Combined ginger extract & Gelam honey modulate Ras/ERK and PI3K/AKT pathway genes in colon cancer HT29 cells,” Nutrition Journal, vol. 14, no. 1, 2015. View at Publisher · View at Google Scholar
  • R. T. Nitta, S. Gholamin, A. H. Feroze, M. Agarwal, S. H. Cheshier, S. S. Mitra, and G. Li, “Casein kinase 2 alpha regulates glioblastoma brain tumor-initiating cell growth through the beta-catenin pathway,” Oncogene, vol. 34, no. 28, pp. 3688–3699, 2015. View at Publisher · View at Google Scholar
  • Lingyun Yang, Pang Xu, Mingrong Xi, and Hongjing Wang, “FIGO stage IV gestational choriocarcinoma misdiagnosed as pulmonary tuberculosis: A case report,” Oncology Letters, vol. 10, no. 3, pp. 1924–1926, 2015. View at Publisher · View at Google Scholar
  • Ji Cheng, Rui Deng, Peng Zhang, Chuanqing Wu, Ke Wu, Liang Shi, Xinghua Liu, Jie Bai, Meizhou Deng, Xiaoming Shuai, Jinbo Gao, Guobin Wang, and Kaixiong Tao, “miR-219-5p plays a tumor suppressive role in colon cancer by targeting oncogene Sall4,” Oncology Reports, vol. 34, no. 4, pp. 1923–1932, 2015. View at Publisher · View at Google Scholar
  • Lydia Rossow, Iris Eke, Ellen Dickreuter, and Nils Cordes, “Targeting of the EGFR/beta 1 integrin connecting proteins PINCH1 and Nck2 radiosensitizes three-dimensional SCC cell cultures,” Oncology Reports, vol. 34, no. 1, pp. 469–476, 2015. View at Publisher · View at Google Scholar
  • Jessica Ribeiro Gomes, and Marcelo Rocha S. Cruz, “Combination of afatinib with cetuximab in patients with EGFR-mutant non-small-cell lung cancer resistant to EGFR inhibitors,” Oncotargets And Therapy, vol. 8, pp. 1137–1142, 2015. View at Publisher · View at Google Scholar
  • Shunchao Yan, Xin Jiao, Kai Li, Wusheng Li, and Huawei Zou, “The impact of IGF-IR expression on the outcomes of patients with breast cancer: a meta-analysis,” Oncotargets And Therapy, vol. 8, pp. 279–287, 2015. View at Publisher · View at Google Scholar
  • S. Koeppen, “Peripheral neurotoxicity. Preventive dosage modification,” Onkologe, vol. 21, no. 4, pp. 311–+, 2015. View at Publisher · View at Google Scholar
  • Isadora Peres Klein, Alessandra Dutra da Silva, Marco Antonio Trevizani Martins, Pantelis Varvaki Rados, Cristiane Machado Mengatto, Manoela Domingues Martins, and Vinicius Coelho Carrard, “Slow-growing mass and expansive swelling in the maxilla,” Oral Surgery Oral Medicine Oral Pathology Oral Radiology, vol. 120, no. 3, pp. 284–290, 2015. View at Publisher · View at Google Scholar
  • Elena Puerta-Garcia, Marisa Canadas-Garre, and Miguel Angel Calleja-Hernandez, “Molecular biomarkers in colorectal carcinoma,” Pharmacogenomics, vol. 16, no. 10, pp. 1189–1221, 2015. View at Publisher · View at Google Scholar
  • Terence M. Myckatyn, Jaime A. Cavallo, Ketan Sharma, Noopur Gangopadhyay, Jason R. Dudas, Andres A. Roma, Sara Baalman, Marissa M. Tenenbaum, Brent D. Matthews, and Corey R. Deeken, “The Impact of Chemotherapy and Radiation Therapy on the Remodeling of Acellular Dermal Matrices in Staged, Prosthetic Breast Reconstruction,” Plastic And Reconstructive Surgery, vol. 135, no. 1, pp. 43E–57E, 2015. View at Publisher · View at Google Scholar
  • Jia Liu, Jing Bai, Guoqiang Jiang, Xinli Li, Jing Wang, Dachang Wu, Lawrence Owusu, Ershao Zhang, and Weiling Li, “Anti-Tumor Effect of Pinus massoniana Bark Proanthocyanidins on Ovarian Cancer through Induction of Cell Apoptosis and Inhibition of Cell Migration,” PLoS One, vol. 10, no. 11, 2015. View at Publisher · View at Google Scholar
  • Nicolas Carels, Tatiana Tilli, and Jack A. Tuszynski, “A Computational Strategy to Select Optimized Protein Targets for Drug Development toward the Control of Cancer Diseases,” Plos One, vol. 10, no. 1, 2015. View at Publisher · View at Google Scholar
  • Yu-Chieh Lee, Chii-Hong Lee, Hsiang-Ping Tsai, Herng-Wei An, Chi-Ming Lee, Jen-Chine Wu, Chien-Shu Chen, Shih-Hao Huang, Jaulang Hwang, Kur-Ta Cheng, Phui-Ly Leiw, Chi-Long Chen, and Chun-Mao Lin, “Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer,” Plos One, vol. 10, no. 7, 2015. View at Publisher · View at Google Scholar
  • Nadege Gaborit, Ali Abdul-Hai, Maicol Mancini, Moshit Lindzen, Sara Lavi, Orith Leitner, Lucile Mounier, Myriam Chentouf, Sai Dunoyer, Manjusha Ghosh, Christel Larbouret, Thierry Chardes, Herve Bazin, Andre Pelegrine, Michael Sela, and Yosef Yarden, “Examination of HER3 targeting in cancer using monoclonal antibodies,” Proceedings Of The National Academy Of Sciences Of The United States Of America, vol. 112, no. 3, pp. 839–844, 2015. View at Publisher · View at Google Scholar
  • Fumiaki Isohashi, Seiji Mabuchi, Yasuo Yoshioka, Yuji Seo, Osamu Suzuki, Keisuke Tamari, Michiko Yamashita, Hikari Unno, Yasuto Kinose, Katsumi Kozasa, Iori Sumida, Yuki Otani, Tadashi Kimura, and Kazuhiko Ogawa, “Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical,” Radiation Oncology, vol. 10, 2015. View at Publisher · View at Google Scholar
  • Prashant Bhatia, “Alternative empiric therapy to carbapenems in management of drug resistant gram negative pathogens: a new way to spare carbapenems,” Research Journal of Infectious Diseases, vol. 3, no. 1, pp. 2, 2015. View at Publisher · View at Google Scholar
  • Hung-Jin Huang, Hsin-Yi Chen, Yuan-Shiun Chang, and Calvin Yu-Chian Chen, “Insight into two antioxidants binding to the catalase NADPH binding site from traditional Chinese medicines,” Rsc Advances, vol. 5, no. 9, pp. 6625–6635, 2015. View at Publisher · View at Google Scholar
  • Caleb Kesse Firempong, Xia Cao, Shanshan Tong, Jiangnan Yu, and Ximing Xu, “Prospects for multitarget lipid-raft-coated silica beads: a remarkable online biomaterial for discovering multitarget antitumor lead compounds,” Rsc Advances, vol. 5, no. 61, pp. 49330–49342, 2015. View at Publisher · View at Google Scholar
  • Biswajit Mishra, Tamara Lushnikova, and Guangshun Wang, “Small lipopeptides possess anti-biofilm capability comparable to daptomycin and vancomycin,” Rsc Advances, vol. 5, no. 73, pp. 59758–59769, 2015. View at Publisher · View at Google Scholar
  • Matthew P. Walker, Charles M. Stopford, Maria Cederlund, Fang Fang, Christopher Jahn, Alex D. Rabinowitz, Dennis Goldfarb, David M. Graham, Feng Yan, Allison M. Deal, Yuri Fedoriw, Kristy L. Richards, Ian J. Davis, Gilbert Weidinger, Blossom Damania, and Michael B. Major, “FOXP1 potentiates Wnt/beta-catenin signaling in diffuse large B cell lymphoma,” Science Signaling, vol. 8, no. 362, 2015. View at Publisher · View at Google Scholar
  • Toru Kono, Yasuyuki Suzuki, Keita Mizuno, Chika Miyagi, Yuji Omiya, Hitomi Sekine, Yasuharu Mizuhara, Kanako Miyano, Yoshio Kase, and Yasuhito Uezono, “Preventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in rats,” Scientific Reports, vol. 5, 2015. View at Publisher · View at Google Scholar
  • Qiong Li, Daoxiang Zhang, Xiaoying Chen, Lei He, Tianming Li, Xiaoping Xu, and Min Li, “Nuclear PKM2 contributes to gefitinib resistance via upregulation of STAT3 activation in colorectal cancer,” Scientific Reports, vol. 5, 2015. View at Publisher · View at Google Scholar
  • Li Liu, Qing Ye, Maggie Lu, Ya-Chin Lo, Yuan-Hung Hsu, Ming-Cheng Wei, Yu-Hsiang Chen, Shen-Chuan Lo, Shian-Jy Wang, Daniel J. Bain, and Chien Ho, “A New Approach to Reduce Toxicities and to Improve Bioavailabilities of Platinum-Containing Anti-Cancer Nanodrugs,” Scientific Reports, vol. 5, 2015. View at Publisher · View at Google Scholar
  • Dalila Naci, Kristiina Vuori, and Fawzi Aoudjit, “Alpha2beta1 integrin in cancer development and chemoresistance,” Seminars in Cancer Biology, 2015. View at Publisher · View at Google Scholar
  • J. S. Davis, S. Van Hal, and S. Y. C. Tong, “Combination Antibiotic Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections,” Seminars In Respiratory And Critical Care Medicine, vol. 36, no. 1, pp. 3–16, 2015. View at Publisher · View at Google Scholar
  • Yuanyuan Han, Yu-Hwa Lo, Ti-Hsuan Ku, Tiantian Zhang, Hua Luo, Tony M. Yen, and Ping-Wei Chen, “Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing,” Sensors, vol. 15, no. 7, pp. 16281–16313, 2015. View at Publisher · View at Google Scholar
  • Julia M. K. Clabbers, Christine B. Boers–Doets, Hans Gelderblom, Theo Stijnen, Mario E. Lacouture, Koos J. M. van der Hoeven, and Adrian A. Kaptein, “Xerosis and pruritus as major EGFRI-associated adverse events,” Supportive Care in Cancer, 2015. View at Publisher · View at Google Scholar
  • In Gyu Hwang, Jung Hun Kang, Sung Yong Oh, Suee Lee, Sung-Hyun Kim, Ki-Hoon Song, Choonhee Son, Min Jae Park, Myung Hee Kang, Hoon Gu Kim, Jeeyun Lee, Young Suk Park, Jong Mu Sun, Hyun Jung Kim, Chan Kyu Kim, Seong Yoon Yi, Joung-Soon Jang, Keunchil Park, and Hyo-Jin Kim, “Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects,” Supportive Care in Cancer, 2015. View at Publisher · View at Google Scholar
  • Tomohisa Mori, Junpei Ohya, Aki Masumoto, Masato Harumiya, Mika Fukase, Kazumi Yoshizawa, Teruo Hayashi, and Tsutomu Suzuki, “Possible Involvement of the Sigma-1 Receptor Chaperone in Chemotherapeutic-Induced Neuropathic Pain,” Synapse, vol. 69, no. 11, pp. 526–532, 2015. View at Publisher · View at Google Scholar
  • M. A. Jallad, R. Naoufal, J. Irani, and E. Azar, “Extended Spectrum Beta-Lactamase Carriage State among Elderly Nursing Home Residents in Beirut,” The Scientific World Journal, vol. 2015, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Yoshitaka Narita, “Bevacizumab for glioblastoma,” Therapeutics And Clinical Risk Management, vol. 11, pp. 1759–1765, 2015. View at Publisher · View at Google Scholar
  • Denisa Margină, Mihaela Ilie, Daniela Grădinaru, Vasilis P. Androutsopoulos, Demetrios Kouretas, and Aristidis Tsatsakis, “Natural products—friends or foes?,” Toxicology Letters, 2015. View at Publisher · View at Google Scholar
  • Denise A. Yardley, Adam Brufsky, Robert E. Coleman, Pierfranco F. Conte, Javier Cortes, Stefan Glueck, Jean-Mark A. Nabholtz, Joyce O'Shaughnessy, Robert M. Beck, Amy Ko, Markus F. Renschler, Debora Barton, and Nadia Harbeck, “Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic ,” Trials, vol. 16, 2015. View at Publisher · View at Google Scholar
  • Stine Ninel Hansen, David Westergaard, Mathilde Borg Houlberg Thomsen, Mette Vistesen, Khoa Nguyen Do, Louise Fogh, Kirstine C. Belling, Jun Wang, Huanming Yang, Ramneek Gupta, Henrik J. Ditzel, Jose Moreira, Nils Brunner, Jan Stenvang, and Anne-Sofie Schrohl, “Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by dis,” Tumor Biology, vol. 36, no. 6, pp. 4327–4338, 2015. View at Publisher · View at Google Scholar
  • Emel Alan, Narin Liman, and Hakan Sagsoz, “The profile of the epidermal growth factor system in rat endometrium during postpartum involution period,” Veterinary Research Communications, vol. 39, no. 2, pp. 115–135, 2015. View at Publisher · View at Google Scholar
  • An Na Seo, Yoonjin Kwak, Woo Ho Kim, Duck-Woo Kim, Sung-Bum Kang, Gheeyoung Choe, and Hye Seung Lee, “HER3 protein expression in relation to HER2 positivity in patients with primary colorectal cancer: clinical relevance and prognostic value,” Virchows Archiv, vol. 466, no. 6, pp. 645–654, 2015. View at Publisher · View at Google Scholar
  • Uwe Wollina, Gesina Hansel, Felicitas Zimmermann, Jacqueline Schönlebe, and Andreas Nowak, “Merkel cell carcinoma of the lower leg with retroperitoneal GIST: a very rare association,” Wiener klinische Wochenschrift, 2015. View at Publisher · View at Google Scholar
  • Marwan Ghosn, Hampig Raphael Kourie, Pamela Abdayem, Joelle Antoun, and Dolly Nasr, “Anal cancer treatment: Current status and future perspectives,” World Journal Of Gastroenterology, vol. 21, no. 8, pp. 2294–2302, 2015. View at Publisher · View at Google Scholar
  • Na Li, Gang Chen, Jue Liu, Yang Xia, Hanbang Chen, Hui Tang, Feimin Zhang, and Ning Gu, “Effect of Surface Topography and Bioactive Properties on Early Adhesion and Growth Behavior of Mouse Preosteoblast MC3T3-E1 Cells,” Acs Applied Materials & Interfaces, vol. 6, no. 19, pp. 17134–17143, 2014. View at Publisher · View at Google Scholar
  • Jing Liu, Il-Hoon Cho, Yi Cui, and Joseph Irudayaraj, “Second Harmonic Super-resolution Microscopy for Quantification of mRNA at Single Copy Sensitivity,” Acs Nano, vol. 8, no. 12, pp. 12418–12427, 2014. View at Publisher · View at Google Scholar
  • Youngseok Lee, Jian Ma, Hui Lyu, Jingcao Huang, and Aeree Kim, “Role of erbB3 receptors in cancer therapeutic resistance,” Acta Biochimica et Biophysica Sinica, vol. 46, no. 3, pp. 190–198, 2014. View at Publisher · View at Google Scholar
  • Maria Hakanson, Edna Cukierman, and Mirren Charnley, “Miniaturized pre-clinical cancer models as research and diagnostic tools,” Advanced Drug Delivery Reviews, vol. 69, pp. 52–66, 2014. View at Publisher · View at Google Scholar
  • Sylvia Kiwuwa-Muyingo, Bernard Kikaire, Ivan Mambule, Helen Musana, Godfrey Musoro, Charles F. Gilks, Jonathan B. Levin, and Anne Sarah Walker, “Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial,” Aids, vol. 28, no. 17, pp. 2579–2588, 2014. View at Publisher · View at Google Scholar
  • Paul Lochhead, Andrew T. Chan, Edward Giovannucci, Charles S. Fuchs, Kana Wu, Reiko Nishihara, Michael O'Brien, and Shuji Ogino, “Progress and Opportunities in Molecular Pathological Epidemiology of Colorectal Premalignant Lesions,” American Journal of Gastroenterology, vol. 109, no. 8, pp. 1205–1214, 2014. View at Publisher · View at Google Scholar
  • Xinghao Ai, Yingjia Sun, Haidong Wang, and Shun Lu, “A systematic profile of clinical inhibitors responsive to EGFR somatic amino acid mutations in lung cancer: implication for the molecular mechanism of drug resistance and sensitivity,” Amino Acids, vol. 46, no. 7, pp. 1635–1648, 2014. View at Publisher · View at Google Scholar
  • Yujun Song, Xuefeng Xia, Xifeng Wu, Ping Wang, and Lidong Qin, “Integration of Platinum Nanoparticles with a Volumetric Bar-Chart Chip for Biomarker Assays,” Angewandte Chemie-International Edition, vol. 53, no. 46, pp. 12451–12455, 2014. View at Publisher · View at Google Scholar
  • Chongjiao Li, Xiaoli Lan, Hui Yuan, Hongyan Feng, Xiaotian Xia, and Yongxue Zhang, “F-18-FDG PET predicts pathological response to preoperative chemoradiotherapy in patients with primary rectal cancer: a meta-analysis,” Annals of Nuclear Medicine, vol. 28, no. 5, pp. 436–446, 2014. View at Publisher · View at Google Scholar
  • Edgar D. Staren, Donald Braun, Bradford Tan, Digant Gupta, Seungchan Kim, Kim Kramer, and Maurie Markman, “Initial Experience with Genomic Profiling of Heavily Pretreated Breast Cancers,” Annals of Surgical Oncology, vol. 21, no. 10, pp. 3216–3222, 2014. View at Publisher · View at Google Scholar
  • Margherita Ratti, “Emerging combination therapies to overcome resistance in EGFR-driven tumors,” Anti-Cancer Drugs, vol. 25, no. 2, pp. 127–139, 2014. View at Publisher · View at Google Scholar
  • Parisa Ghanbari, Mahsa Mohseni, Maryam Tabasinezhad, Bahman Yousefi, Amir Ata Saei, Simin Sharifi, Mohammad Reza Rashidi, and Nasser Samadi, “Inhibition of Survivin Restores the Sensitivity of Breast Cancer Cells to Docetaxel and Vinblastine,” Applied Biochemistry and Biotechnology, 2014. View at Publisher · View at Google Scholar
  • Sabit Sinan Ozalp, Elcin Telli, Tufan Oge, Gokhan Tulunay, Nurettin Boran, Taner Turan, Mufit Yenen, Zehra Kurdoglu, Ali Ozler, Kunter Yuce, Volkan Ulker, Macit Arvas, Fuat Demirkiran, Tugan Bese, Nedim Tokgozoglu, Anil Onan, Muzaffer Sanci, Mehmet Gokcu, Gokhan Tosun, Yilmaz Dikmen, Aydin Ozsaran, Mustafa Cosan Terek, Levent Akman, Hakan Yetimalar, Derya Sakarya Kilic, Tayfun Gungor, Emre Ozgu, Yunus Yildiz, Arif Kokcu, Mehmet Kefeli, Serkan Kuruoglu, Hasan Yuksel, Tevfik Guvenal, Pinar Solmaz Hasdemir, Bulent Ozcelik, Serdar Serin, Mehmet Dolanbay, Dagistan Tolga Arioz, Nadire Tuncer, Hasan Bozkaya, Suleyman Guven, Deniz Kulaksiz, Fusun Varol, Ali Yanik, Gonca Ogurlu, Tayyup Simsek, Tayfun Toptas, Selen Dogan, Hakan Camuzoglu, Murat Api, Kadir Guzin, Eray Caliskan, Emek Doger, Bulent Cakmak, and Tolgay Tuyan Ilhan, “Multicenter Analysis of Gestational Trophoblastic Neoplasia in Turkey,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 8, pp. 3625–3628, 2014. View at Publisher · View at Google Scholar
  • Nusrat Bano, Rahila Najam, Faaiza Qazi, and Ahmed Mateen, “Gastrointestinal Adverse Effects in Advanced Colorectal Carcinoma Patients Treated with Different Schedules of FOLFOX,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 19, pp. 8089–8093, 2014. View at Publisher · View at Google Scholar
  • Saul Renan Leon-Hernandez, Eleazar Lara Padilla, Alfredo Cortes Algara, Noemi Cardenas Rodriguez, Esau Floriano Sanchez, Jaime Lopez Cruz, Cesar Miguel Mejia Barradas, and Cindy Bandala, “Relation of Alcohol/Tobacco use with Metastasis, Hormonal (Estrogen and Progesterone) Receptor Status and c-erbB2 Protein in Mammary Ductal Carcinoma,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 14, pp. 5709–5714, 2014. View at Publisher · View at Google Scholar
  • Helen Creedon, Adam Byron, Joanna Main, Larry Hayward, Teresa Klinowska, and Valerie G. Brunton, “Exploring mechanisms of acquired resistance to HER2 (human epidermal growth factor receptor 2)-targeted therapies in breast cancer,” Biochemical Society Transactions, vol. 42, pp. 822–830, 2014. View at Publisher · View at Google Scholar
  • Veronica Morente, Raquel Perez-Sen, Felipe Ortega, Jaime Huerta-Cepas, Esmerilda G. Delicado, and Ma Teresa Miras-Portugal, “Neuroprotection elicited by P2Y(13) receptors against genotoxic stress by inducing DUSP2 expression and MAPK signaling recovery,” Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1843, no. 9, pp. 1886–1898, 2014. View at Publisher · View at Google Scholar
  • J. A. Smith, T. Leonardi, B. Huang, N. Iraci, B. Vega, and S. Pluchino, “Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases,” Biogerontology, 2014. View at Publisher · View at Google Scholar
  • Yijie Lu, Ghislaine Ngo Ndjock Mbong, Peng Liu, Conrad Chan, Zhongli Cai, Dirk Weinrich, Amanda J. Boyle, Raymond M. Reilly, and Mitchell A. Winnik, “Synthesis of Polyglutamide-Based Metal-Chelating Polymers and Their Site-Specific Conjugation to Trastuzumab for Auger Electron Radioimmunotherapy,” Biomacromolecules, vol. 15, no. 6, pp. 2027–2037, 2014. View at Publisher · View at Google Scholar
  • Sandhya V. G. Nair, Menik Hettihewa, and H. P. Vasantha Rupasinghe, “Apoptotic and Inhibitory Effects on Cell Proliferation of Hepatocellular Carcinoma HepG2 Cells by Methanol Leaf Extract of Costus speciosus,” BioMed Research International, vol. 2014, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  • Peeyush N. Goel, and Rajiv P. Gude, “Pentoxifylline regulates the cellular adhesion and its allied receptors to extracellular matrix components in breast cancer cells,” Biomedicine & Pharmacotherapy, vol. 68, no. 1, pp. 93–99, 2014. View at Publisher · View at Google Scholar
  • Liyan Jiang, Wei Zhu, Katie Streicher, Chris Morehouse, Philip Brohawn, Xiaoxiao Ge, Zhengwei Dong, Xiaolu Yin, Guanshan Zhu, Yi Gu, Koustubh Ranade, Brandon W. Higgs, Yihong Yao, and Jiaqi Huang, “Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Graziele Fonseca de Sousa, Samarina Rodrigues Wlodarczyk, and Gisele Monteiro, “Carboplatin: molecular mechanisms of action associated with chemoresistance,” Brazilian Journal Of Pharmaceutical Sciences, vol. 50, no. 4, pp. 693–701, 2014. View at Publisher · View at Google Scholar
  • Xinghua Li, Weijiang Liang, Junling Liu, Chuyong Lin, Shu Wu, Libing Song, and Zhongyu Yuan, “Transducin (beta)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling,” Breast Cancer Research, vol. 16, no. 5, 2014. View at Publisher · View at Google Scholar
  • Lu Chen, Hannah M. Linden, Benjamin O. Anderson, and Christopher I. Li, “Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage,” Breast Cancer Research and Treatment, vol. 147, no. 3, pp. 609–616, 2014. View at Publisher · View at Google Scholar
  • C. L. Schwab, S. Bellone, D. P. English, D. M. Roque, S. Lopez, E. Cocco, R. Nicoletti, I. Bortolomai, E. Bonazzoli, E. Ratner, D-A Silasi, M. Azodi, P. E. Schwartz, T. J. Rutherford, and A. D. Santin, “Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo,” British Journal of Cancer, vol. 111, no. 9, pp. 1750–1756, 2014. View at Publisher · View at Google Scholar
  • S. Li, L. Li, Y. Zhu, C. Huang, Y. Qin, H. Liu, L. Ren-Heidenreich, B. Shi, H. Ren, X. Chu, J. Kang, W. Wang, J. Xu, K. Tang, H. Yang, Y. Zheng, J. He, G. Yu, and N. Liang, “Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts,” British Journal of Cancer, vol. 110, no. 11, pp. 2812–2820, 2014. View at Publisher · View at Google Scholar
  • M. Koczywas, P. H. Frankel, T. W. Synold, H-J Lenz, J. E. Mortimer, A. B. El-Khoueiry, D. R. Gandara, M. C. Cristea, V. M. Chung, D. Lim, K. L. Reckamp, D. H. Lau, L. A. Doyle, C. Ruel, M. I. Carroll, and E. M. Newman, “Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors,” British Journal Of Cancer, vol. 111, no. 12, pp. 2268–2274, 2014. View at Publisher · View at Google Scholar
  • Matthew T. Balmer, Ryan D. Katz, Si Liao, James S. Goodwine, and Susannah Gal, “Doxorubicin and 5-fluorouracil induced accumulation and transcriptional activity of p53 are independent of the phosphorylation at serine 15 in MCF-7 breast cancer cells,” Cancer Biology & Therapy, vol. 15, no. 8, pp. 1000–1012, 2014. View at Publisher · View at Google Scholar
  • Malgorzata K. Tuxen, and Dorte Lisbet Nielsen, “A systematic review of dual targeting in HER2-positive breast cancer,” Cancer Treatment Reviews, vol. 40, no. 2, pp. 259–270, 2014. View at Publisher · View at Google Scholar
  • Lijuan Yang, Yuexun Wang, Hua Guo, and Meiling Guo, “Synergistic Anti-Cancer Effects of Icariin and Temozolomide in Glioblastoma,” Cell Biochemistry and Biophysics, 2014. View at Publisher · View at Google Scholar
  • Dalila Naci, and Fawzi Aoudjit, “Alpha2beta1 integrin promotes T cell survival and migration through the concomitant activation of ERK/Mcl-1 and p38 MAPK pathways,” Cellular Signalling, 2014. View at Publisher · View at Google Scholar
  • Linlin Tang, Bin Yue, Yanna Cheng, Hong Yao, Xiaowen Ma, Qi Tian, Lianping Ge, Zhaopeng Liu, and Xiuzhen Han, “Inhibition of invasion and metastasis by DMBT, a novel trehalose derivative, through Akt/GSK-3 beta/beta-catenin pathway in B16BL6 cells,” Chemico-Biological Interactions, vol. 222, pp. 7–17, 2014. View at Publisher · View at Google Scholar
  • Hilde van Hattum, and Herbert Waldmann, “Chemical Biology Tools for Regulating RAS Signaling Complexity in Space and Time,” Chemistry & Biology, vol. 21, no. 9, pp. 1185–1195, 2014. View at Publisher · View at Google Scholar
  • Lidia Zueva, Yomarie Rivera, Lilia Kucheryavykh, Serguei N. Skatchkov, Misty J. Eaton, Priscila Sanabria, and Mikhail Inyushin, “Electron Microscopy in Rat Brain Slices Reveals Rapid Accumulation of Cisplatin on Ribosomes and Other Cellular Components Only in Glia,” Chemotherapy Research and Practice, vol. 2014, pp. 1–5, 2014. View at Publisher · View at Google Scholar
  • Ebenezer Tunde Olayinka, Ayokanmi Ore, Olaniyi Solomon Ola, and Oluwatobi Adewumi Adeyemo, “Protective Effect of Quercetin on Melphalan-Induced Oxidative Stress and Impaired Renal and Hepatic Functions in Rat,” Chemotherapy Research and Practice, vol. 2014, pp. 1–8, 2014. View at Publisher · View at Google Scholar